Your browser doesn't support javascript.
loading
CYP3A5 genotype is associated with longer patient survival after kidney transplantation and long-term treatment with cyclosporine.
Kreutz, R; Bolbrinker, J; van der Sman-de Beer, F; Boeschoten, E W; Dekker, F W; Kain, S; Martus, P; Sietmann, A; Friedrichs, F; Stoll, M; Offermann, G; Beige, J.
Affiliation
  • Kreutz R; Department of Clinical Pharmacology, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Berlin, Germany. reinhold.kreutz@charite.de
Pharmacogenomics J ; 8(6): 416-22, 2008 Dec.
Article in En | MEDLINE | ID: mdl-18180803
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Cyclosporine / Cytochrome P-450 CYP3A / Immunosuppressive Agents Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2008 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Cyclosporine / Cytochrome P-450 CYP3A / Immunosuppressive Agents Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Pharmacogenomics J Journal subject: BIOLOGIA MOLECULAR / FARMACOLOGIA Year: 2008 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos